Literature DB >> 25585700

Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.

Claire Dandine-Roulland1,2, Hervé Perdry1,2.   

Abstract

Many associated single-nucleotide polymorphisms (SNPs) have been identified by association studies for numerous diseases. However, the association between a SNP and a disease can result from a causal variant in linkage disequilibrium (LD) with the considered SNP. Assuming that the true causal variant is among the genotyped SNPs, other authors demonstrated that the power to discriminate between it and other SNPs in LD is low. Here, we propose to take advantage of the information provided by family data to improve the inference on the causal variant: we exploit the linkage information provided by affected sib pairs to discriminate the causal variant from the associated SNPs. The family-based approach improves discrimination power requiring up to five times less individuals than its case-control equivalent. However, the main advantage of family design is the possibility to carry out the procedure one step further: the linkage information allows inference on causal variants, which are not genotyped but in LD with tag-SNPs displaying association, which is impossible with case-control design. By means of Bayesian methods, we estimate the LD between the observed SNPs and an unobserved causal variant, as well as the allelic odds ratio at the unobserved causal variant. The proposed procedure is illustrated on a multiple sclerosis (MS) family data set including genotypes of SNPs in IL2RA, confirming the advantage of using a family design to identify causal variants. The results of our method on this data suggest the existence of two distinct causal variants in this gene for the MS.

Entities:  

Mesh:

Year:  2015        PMID: 25585700      PMCID: PMC4592080          DOI: 10.1038/ejhg.2014.284

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  24 in total

1.  Evaluating the power to discriminate between highly correlated SNPs in genetic association studies.

Authors:  Miriam S Udler; Jonathan Tyrer; Douglas F Easton
Journal:  Genet Epidemiol       Date:  2010-07       Impact factor: 2.135

2.  Genomewide study of multiple sclerosis.

Authors:  Sreeram V Ramagopalan; Carl Anderson; A Dessa Sadovnick; George C Ebers
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

3.  A new method to test genetic models in HLA associated diseases: the MASC method.

Authors:  F Clerget-Darpoux; M C Babron; B Prum; G M Lathrop; I Deschamps; J Hors
Journal:  Ann Hum Genet       Date:  1988-07       Impact factor: 1.670

4.  Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource.

Authors:  Calliope A Dendrou; Vincent Plagnol; Erik Fung; Jennie H M Yang; Kate Downes; Jason D Cooper; Sarah Nutland; Gillian Coleman; Matthew Himsworth; Matthew Hardy; Oliver Burren; Barry Healy; Neil M Walker; Kerstin Koch; Willem H Ouwehand; John R Bradley; Nicholas J Wareham; John A Todd; Linda S Wicker
Journal:  Nat Genet       Date:  2009-08-23       Impact factor: 38.330

5.  Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.

Authors:  J P Rubio; J Stankovich; J Field; N Tubridy; M Marriott; C Chapman; M Bahlo; D Perera; L J Johnson; B D Tait; M D Varney; T P Speed; B V Taylor; S J Foote; H Butzkueven; T J Kilpatrick
Journal:  Genes Immun       Date:  2008-07-24       Impact factor: 2.676

6.  Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses.

Authors:  Lisa M Maier; David E Anderson; Christopher A Severson; Clare Baecher-Allan; Brian Healy; David V Liu; K Dane Wittrup; Philip L De Jager; David A Hafler
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

7.  IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility.

Authors:  Fuencisla Matesanz; Alfredo Caro-Maldonado; Maria Fedetz; Oscar Fernández; Roger L Milne; Miguel Guerrero; Concepción Delgado; Antonio Alcina
Journal:  J Neurol       Date:  2007-04-10       Impact factor: 4.849

8.  IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D).

Authors:  Antonio Alcina; María Fedetz; Dorothy Ndagire; Oscar Fernández; Laura Leyva; Miguel Guerrero; María M Abad-Grau; Carmen Arnal; Concepción Delgado; Miguel Lucas; Guillermo Izquierdo; Fuencisla Matesanz
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

9.  Progress in multiple sclerosis genetics.

Authors:  An Goris; Ine Pauwels; Bénédicte Dubois
Journal:  Curr Genomics       Date:  2012-12       Impact factor: 2.236

10.  Modeling the effect of PTPN22 in rheumatoid arthritis.

Authors:  Mathieu Bourgey; Hervé Perdry; Françoise Clerget-Darpoux
Journal:  BMC Proc       Date:  2007-12-18
View more
  1 in total

1.  The genetics of venous thromboembolism: a systematic review of thrombophilia families.

Authors:  Yu Zhang; Zhu Zhang; Shi Shu; Wenquan Niu; Wanmu Xie; Jun Wan; Zhenguo Zhai; Chen Wang
Journal:  J Thromb Thrombolysis       Date:  2021-02       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.